Work

Supplementary Figure 4 from Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 4 from Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies

DOI: 10.1158/0008-5472.22370163.v1

Authors: Zhiwei Yu, Titus J. Boggon, Susumu Kobayashi, Cheng Jin, Patrick C. Ma, Afshin Dowlati, Jeffrey A. Kern, Daniel G. Tenen, Balázs Halmos

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361247517

Cites:

Cited by:

Related to: 10